Long-term persistence of HCV resistance-associated substitutions after DAA treatment failureJulia Dietz, Jochen Weigt, Beat Müllhaupt et al.|Journal of Hepatology|2022Cited by 26
Prevalence of resistance-associated substitutions and retreatment of patients failing a glecaprevir/pibrentasvir regimenAdolfo de Salazar, Eiko Schnaitmann, Julia Dietz et al.|Journal of Antimicrobial Chemotherapy|2020Cited by 22
Efficacy of Retreatment After Failed Direct-acting Antiviral Therapy in Patients With HCV Genotype 1–3 InfectionsJulia Dietz, F. Kocheise, Ulrich Spengler et al.|Clinical Gastroenterology and Hepatology|2019Cited by 13
Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patientsJulia Dietz, R. Zachoval, Christiana Graf et al.|JHEP Reports|2024Cited by 8
The prognostic relevance of pleural effusion in patients with COVID-19 - A German multicenter studyAndreas Bucher, Alexey Surov, Julia Dietz et al.|Clinical Imaging|2024Cited by 2